Literature DB >> 19646971

Extracellular serotonin level in the basolateral nucleus of the amygdala and dorsal periaqueductal gray under unconditioned and conditioned fear states: an in vivo microdialysis study.

Janaina M Zanoveli1, Milene C Carvalho, Joice M Cunha, Marcus L Brandão.   

Abstract

Serotonin (5-HT) plays a key role in the neural circuitry mediating unconditioned and conditioned fear responses related to panic and generalized anxiety disorders. The basolateral nucleus of the amygdala (BLA) and the dorsal periaqueductal gray (dPAG) appear to be mainly involved in these conditions. The aim of this study was to measure the extracellular level of 5-HT and its metabolite 5-hydroxyindolacetic acid (5-HIAA) in the BLA and dPAG during unconditioned and conditioned fear states using in vivo microdialysis procedure. Thus, for the unconditioned fear test, animals were chemically stimulated in the dPAG with semicarbazide, an inhibitor of the gamma-aminobutyric acid-synthesizing enzyme glutamic acid decarboxylase. For the conditioned fear test, animals were subjected to a contextual conditioned fear paradigm using electrical footshock as the unconditioned stimulus. The results show that the 5-HT and 5-HIAA level in the BLA and dPAG did not change during unconditioned fear, whereas 5-HT concentration, but not 5-HIAA concentration, increased in these brain areas during conditioned fear. The present study showed that the 5-HT system was activated during conditioned fear, whereas it remained unchanged during unconditioned fear, supporting the hypothesis that 5-HT has distinct roles in conditioned and unconditioned fear (dual role of 5-HT in anxiety disorders).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19646971     DOI: 10.1016/j.brainres.2009.07.074

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  21 in total

1.  Pharmacological depletion of serotonin in the basolateral amygdala complex reduces anxiety and disrupts fear conditioning.

Authors:  Philip L Johnson; Andrei Molosh; Stephanie D Fitz; Dave Arendt; Gerald A Deehan; Lauren M Federici; Cristian Bernabe; Eric A Engleman; Zachary A Rodd; Christopher A Lowry; Anantha Shekhar
Journal:  Pharmacol Biochem Behav       Date:  2015-11       Impact factor: 3.533

2.  Reduced amygdala serotonin transporter binding in posttraumatic stress disorder.

Authors:  James W Murrough; Yiyun Huang; Jian Hu; Shannan Henry; Wendol Williams; Jean-Dominique Gallezot; Christopher R Bailey; John H Krystal; Richard E Carson; Alexander Neumeister
Journal:  Biol Psychiatry       Date:  2011-12-01       Impact factor: 13.382

Review 3.  Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders.

Authors:  N Singewald; C Schmuckermair; N Whittle; A Holmes; K J Ressler
Journal:  Pharmacol Ther       Date:  2014-12-27       Impact factor: 12.310

Review 4.  Serotonergic innervation of the amygdala: targets, receptors, and implications for stress and anxiety.

Authors:  Esther Asan; Maria Steinke; Klaus-Peter Lesch
Journal:  Histochem Cell Biol       Date:  2013-03-15       Impact factor: 4.304

Review 5.  Recent progress in understanding the pathophysiology of post-traumatic stress disorder: implications for targeted pharmacological treatment.

Authors:  Christopher R Bailey; Elisabeth Cordell; Sean M Sobin; Alexander Neumeister
Journal:  CNS Drugs       Date:  2013-03       Impact factor: 5.749

6.  Involvement of serotonin-mediated neurotransmission in the dorsal periaqueductal gray matter on cannabidiol chronic effects in panic-like responses in rats.

Authors:  Alline Cristina Campos; Vanessa de Paula Soares; Milene C Carvalho; Frederico Rogerio Ferreira; Maria Adrielle Vicente; Marcus Lira Brandão; Antonio Waldo Zuardi; Hélio Zangrossi; Francisco Silveira Guimarães
Journal:  Psychopharmacology (Berl)       Date:  2012-09-25       Impact factor: 4.530

7.  Stress Enables Reinforcement-Elicited Serotonergic Consolidation of Fear Memory.

Authors:  Michael V Baratta; Suhasa B Kodandaramaiah; Patrick E Monahan; Junmei Yao; Michael D Weber; Pei-Ann Lin; Barbara Gisabella; Natalie Petrossian; Jose Amat; Kyungman Kim; Aimei Yang; Craig R Forest; Edward S Boyden; Ki A Goosens
Journal:  Biol Psychiatry       Date:  2015-07-02       Impact factor: 13.382

8.  Reestablishment of the hyperglycemia to the normal levels seems not to be essential to the anxiolytic-like effect induced by insulin.

Authors:  Eder Gambeta; Camila Pasquini de Souza; Helen de Morais; Janaina Menezes Zanoveli
Journal:  Metab Brain Dis       Date:  2015-11-25       Impact factor: 3.584

Review 9.  Augmentation of Extinction and Inhibitory Learning in Anxiety and Trauma-Related Disorders.

Authors:  Lauren A M Lebois; Antonia V Seligowski; Jonathan D Wolff; Sarah B Hill; Kerry J Ressler
Journal:  Annu Rev Clin Psychol       Date:  2019-01-30       Impact factor: 18.561

10.  Increased Serotonin Transporter Expression Reduces Fear and Recruitment of Parvalbumin Interneurons of the Amygdala.

Authors:  Marco Bocchio; Giulia Fucsina; Lydia Oikonomidis; Stephen B McHugh; David M Bannerman; Trevor Sharp; Marco Capogna
Journal:  Neuropsychopharmacology       Date:  2015-06-08       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.